ABSTRACT UC 729-6, a 6-thioguanine-resistant human lymphoblastoid B-cell line, was fused with normal and malignant human lymphocytes. Parent UC 729-6 cells were diploid with a 21p+ marker chromosome, expressed surface and cytoplasmic IgM Kc, and doubled every 17 hr. The resulting human-human hybridomas were pseudotetraploid containing the 21p+ marker, doubled every 20-30 hr, and secreted 3-9 jig of human Ig per ml per 106 hybrid cells for >9 months in continuous culture. Human Ig-secreting hybridomas were generated in 88% (14/16) of the fusions carried out and were cloned by limiting dilution (one cell per three wells) without the use of feeder layers. The mean fusion frequencies (number of wells, plated at 105 cells per well, showing hybrid growth per 106 lymphocytes fused) of UC 729-6 with normal lymphocytes ranged from 0.45 to 2.9 and with malignant B lymphocytes, from 3 to 10. Analysis of the human-human hybridomas derived from lymphocytes isolated from regional draining lymph nodes of cancer patients revealed several that secreted human monoclonal antibody that reacted by an enzyme immunoassay with some carcinoma cell lines but not with normal fibroblast cell lines. These data suggest that (i) UC 729-6 can be fused with human lymphocytes to generate stable human-human hybridomas, some of which secrete antibody reactive to human cell surface antigens, and (ii) UC 729-6 can be used to rescue Ig from nonsecretory malignant B cells and thereby allow for the production of anti-idiotype antibodies.
The use of somatic cell hybridization to produce monoclonal antibodies (mAbs) of predefined specificity, as pioneered by Kohler and Milstein (1) , has revolutionized many areas of human biology. However, since most of these mAbs are of rodent origin their application to in vivo use in humans may be limited. Therefore, the production of human mAbs could potentially be of considerable value and in many instances may offer advantages over mAbs of other species.
Currently available human mAbs have been obtained by mouse-human hybridizations (2) (3) (4) , by Epstein-Barr virus (EBV) transformation of human immune lymphocytes (5) (6) (7) , and by human-human hybridization (8) (9) (10) and has recently been reviewed (11) . However, each of these approaches suffers from individual difficulties and each has met with limited success. Mouse-human hybrids preferentially lose human chromosomes and, therefore, are genetically unstable (12, 13) . EBV transformation yields cell lines that produce small quantities of Ig (5) (6) (7) . The reproducibility of generating human-human hybridomas is limited by the lack of a suitable fusion partner in that currently available cell lines for fusion (8) (9) (10) are difficult to work with, have low fusion frequencies, and occasionally yield revertants.
The production of human mAbs of predefined specificity to human tumor-associated antigens would require the availability of a human B lymphocyte sensitized to the host's own tumor.
Recently, investigators have shown that B lymphocytes isolated from regional draining lymph nodes of cancer patients secrete antibodies that recognize the host's tumor (3, 4 MATERIALS AND METHODS UC 729-6. UC 729-6 is a 6-thioguanine-resistant human lymphoblastoid B-cell line isolated by treating parent WIL-2 cells (14, 15) with 25 ,uM 6-thioguanine (16) . UC 729-6 is surface and cytoplasmic IgM K+, diploid with a 21p+ marker chromosome, and Fc fragment receptor negative (17, 18) . Prior to fusion, the cells were incubated with 100 p.M 6-thioguanine (Sigma 
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RPMI 1640 medium and trimmed free of extraneous tissue and capsular components. After transfer to a fresh solution of serumfree RPMI 1640 medium, the tissue was teased with nugent forceps to make a single cell suspension. After large tissue aggregates had settled, the cells in suspension were removed and washed for two 5-min periods at 500 x g. All dissections and cell preparations were carried out at room temperature. All isolated lymphocytes were resuspended at 5 X 106/ml in RPMI 1640 medium/10% fetal calf serum and incubated overnight at 37°C in humidified 5% C02/95% air.
Fusion and Cloning of Hybridomas. UC 729-6 was fused with isolated lymphocytes at a ratio of 1:2 according to the technique of Kohler and Milstein (1) as modified by Gefter et al. (20) . Briefly, UC 729-6 cells were mixed with the isolated lymphocytes in separate 50-ml conical centrifuge tubes (Corning) and washed for two 5-min periods at 500 x g. The supernatant was completely aspirated and 1.0 ml of 35% polyethylene glycol 1500 (BDH; lot no. 6229890) was added dropwise over a 30-sec interval to a dry cell pellet and allowed to stand at room temperature for 2 min. At 2-min intervals, the following volumes of serum-free RPMI 1640 medium were added: 1.0 ml, 2.0 ml, 4.0 ml, and 8.0 ml. After addition of the final 8.0-ml volume of medium, the cells were spun at 300 X g for 5 min, the supernatant was aspirated, and the pellet was carefully suspended in medium supplemented with 10% fetal calf serum, gluta- Detection and Quantitation of Human Ig. Cell surface and cytoplasmic Ig was detected by indirect immunofluorescence microscopy using techniques and reagents previously described (22) . Human Ig-secretinghybridomas were detected by an ELISA as described (23) .
Reactivity of Human mAbs with Cell Lines. Washed logarithmic phase cells (1 x 105) were incubated for 30 min with human mAbs in an immunofiltration manifold plate, washed three times with 0.1% gelatin in NaH2PO4/Na2HPO4/0.9% saline, pH 7.4 (Pi/NaCI), incubated an additional 30 min with horseradish peroxidase conjugated goat anti-human Ig, washed, and developed with o-phenylenediamine as described (23) . Assays were carried out in triplicate and read at 490 nm on a micro-ELISA reader (Dynatech, Alexandria, VA). Controls consisted of Pi/NaCl, supernatant from UC 729-6 cultures, and irrelevant affinity-purified human Igs (Cappell Laboratories, Cochranville, PA). Chromosome Analysis. Cells were incubated for 3.5 hr at 370C with colcemid at 10 Ag/ml (Sigma) in Pi/NaCl. After an additional 30-min incubation in 75 mM KCl, cells were washed (500 x g for 10 min) and fixed with methanol/acetic acid (3:1). Cells were then treated with trypsin (24) and stained with Giemsa for 10 min. Representative chromosome spreads were counted. Frequency Distribution of Cell DNA Content. Cells and hybridomas were stained by the propidium iodide method for the determination of relative cell DNA content and analyzed by cytofluorometry, as described (25) . Briefly, 1.0 x 106 cells were fixed in 70% ethanol for 2 hr, washed (500 X g for 10 min), and then suspended in 100 p1 of Pi/NaCl. One milliliter of propidium iodide (0.05 mg/ml; Sigma) was added to the cell suspension, and the mixture was incubated for 15 min at 40C and filtered through a 50-,um-pore nylon mesh. Samples were analyzed on an Ortho Cytofluorograf 50H-computer 2150 equipped with a 488-mm argon ion laser at 400 mW.
Detection of T65 Antigens. T65 is a T-lymphocyte antigen found on most chronic lymphocytic leukemia (CLL) cells that are surface Ig' (22) but not on lymphoblastoid B-cell lines, including UC 729-6 (18). T65 was detected by indirect immunofluorescence using the murine mAbs T101 previously described (22) .
RESULTS
Characteristics of UC 729-6. UC 729-6, a hypoxanthine phosphoribosyltransferase-negative cell line derived from parental WIL-2 cells (16), was resistant to 100 ,uM 6-thioguanine and died within 10 days when exposed to HAT medium (Fig.  1) . UC 729-6 has remained HAT sensitive for at least 50 passages in the presence of 100 .tM 6-thioguanine and has a doubling time of 17 hr (Fig. 1) 83% of the attempts (three out of three for CLL and two out of three for lymphoma) and fusion frequencies of 3-10 (data not shown). All of the resulting hybrids secreted Ig, all of which were either monoclonal K or A.
Characteristics of Selected Human-Human Hybridomas. Some of the characteristics of selected human-human hybridomas produced in this study, designated 8A1, 8B1, CLNH5, CLNH1l, and WLNA6, are given in Table 2 . Hybridomas 8A1 and 8B1 were the product of fusion of UC 729-6 with the peripheral blood of a patient with CLL (18) [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] hr. The properties of these human-human hybridomas have remained unchanged after preservation in liquid nitrogen and they have reconstituted reliably. Fig. 2 . UC 729-6 is diploid with the presence of the 21p+ chromosome marker (Fig. 2A) . 8A1 is pseudotetraploid and also contains the 21p+ chromosome marker (Fig. 2B) .
Relative DNA contents of diploid lymphocytic cells, UC 729-6 cells, and the pseudotetraploid hybridoma CLNH5 are shown in Fig. 3 . On a scale of 200 units, the relative DNA content of CLNH5 (83 units) is approximately the sum of the peak of UC 729-6 (45 units) plus that of a diploid lymphocyte (42 units).
Immunoreactivity of Human mAbs. The supernatants of human Ig-secreting hybridomas were screened against a panel of human cell lines and those that showed reactivity by ELISA were then cloned by limiting dilution. Two IgM-secreting hybridomas, CLNH5 and WLNA6, were chosen for further analysis because their supernatants reacted with some cell lines (Table   A   ALLL   B   100  200  Relative  DNA One problem associated with the generation of human mAbs is the availability of a suitable cell line for the production of stable human-human hybridomas. Others have shown that mouse-human hybridomas secrete human mAbs (5-7); however, they are genetically unstable and preferentially eliminate human chromosomes (12, 13) , contributing to the difficulty in maintaining these Ig-secreting hybridomas. EBV-transformed human immune lymphocytes are considered poor producers of antibody (5) (6) (7) . In comparison with other human cell lines used for human hybridoma production (8) (9) (10) (11) , UC 729-6 compares favorably. The LICR LON/HMy2 cell line (10) yielded hybrids that secreted Ig at 0.25-2 Jg/ml, while the SKO-007 line (8) yielded hybrids that secreted 3-11 jig/ml; there is no published secretion rate for the GM 1500 6TG-A12 cell line (9) 27 ). The fusion frequencies of UC 729-6 were 0.45-2.9 for normal lymphocytes (Table 1 ) and 3-10 for malignant lymphocytes (unpublished data). In light of the vast difference in immune status between hyperimmune mouse splenocytes and normal human lymphocytes one might expect a large variation in fusion frequencies; Generally, the fusion of normal human lymphocytes with UC 729-6 yields fewer hybrids whereas that between UC 729-6 and malignant human lymphocytes yields-an equal or larger number of hybrids than the established murine hybridoma protocols. Therefore, the UC 729-6 human hybridoma system compares favorably with the murine hybridoma system. This study also confirms previous observations (28) that Ig secretion can be rescued from nonsecretory malignant human B cells by somatic cell hybridization techniques. Therefore, UC 729-6 can serve as a fusion partner in isolation of the malignant B-cell idiotype for the production of anti-idiotype antibodies. Such anti-idiotype antibodies may be useful-for in vivo treatment of B-cell malignancies (29) .
The production and identification of the CLNH5 and WLNA6 hybridomas confirm previous observations (3, 4) of the presence of lymphocytes in lymph nodes that produce alloreactive antibodies to human antigens. Details pertaining to the properties of these human mAbs and their selectivity to malignant cells as compared with normal cells will be described elsewhere. In particular, we have also shown that the CLNH5 mAb binds to autologous cervical carcinoma cells in tissue sections and to autologous cervical carcinomas grown in nude mice (unpublished data).
The availability of human mAbs should provide investigators an opportunity to rigorously study the spectrum of the human B-lymphocyte repertoire 
